Frist Cressey Ventures Company Profile

Background

Frist Cressey Ventures (FCV) is a Nashville-based venture capital firm established in 2016 by former U.S. Senate Majority Leader Bill Frist, M.D., and Bryan Cressey, J.D., M.B.A. The firm is dedicated to accelerating the growth of high-potential healthcare enterprises through value-added partnerships. FCV invests in technology and service businesses that offer viable solutions to enhance the quality of care, system integration, patient outcomes, and population health. The firm collaborates with entrepreneurs who share similar core values in their pursuit to improve healthcare.

Key Strategic Focus

FCV's strategic focus centers on investing in early to late-stage companies within the healthcare sector, particularly in areas such as InsurTech, Health & Wellness, and Software. The firm seeks to partner with ventures that bring inspiration and new ideas for genuine healthcare change, aiming to build transformative healthcare organizations. FCV emphasizes investments in companies that demonstrate strong clinical outcomes, leverage technology to bring new products and services to market, and have the potential to revolutionize care delivery, quality, and integration.

Financials and Funding

As of 2023, FCV manages over $400 million in capital and has invested in more than 20 healthcare and healthtech-oriented partnerships. The firm has raised multiple funds, including a $200 million Fund III launched in 2021, which was later increased to a $300 million target. In May 2025, FCV filed for its $400 million Fund IV, with $169.7 million raised at that point.

Pipeline Development

FCV has made 60 investments, with 29 active portfolio companies and 10 exits. Notable investments include:

Thyme Care: A managed care company focused on improving patient outcomes.

MD Ally: A healthcare services provider enhancing system integration.

Praia Health: A medical records systems company aiming to improve quality of care.

CodaMetrix: A healthcare technology company focusing on system integration.

Blackbird Health: A healthcare services provider dedicated to enhancing patient outcomes.

These investments reflect FCV's commitment to supporting companies that align with their mission to transform healthcare and improve lives.

Technological Platform and Innovation

FCV distinguishes itself through its focus on value-added partnerships and its commitment to investing in technology and service businesses that offer viable solutions to enhance the quality of care, system integration, patient outcomes, and population health. The firm collaborates with entrepreneurs who share similar core values in their pursuit to improve healthcare.

Leadership Team

Bill Frist, M.D.: Co-Founder & Managing Partner. Former U.S. Senate Majority Leader and heart and lung transplant surgeon. Dr. Frist brings extensive experience in healthcare policy and leadership.

Bryan Cressey, J.D., M.B.A.: Co-Founder & Senior Advisor. Founder and Managing Partner of Cressey & Company, a private equity firm focused on healthcare and information technology opportunities.

Christopher Booker: Partner. Leads investment activities and portfolio management, with a focus on identifying and supporting high-potential healthcare enterprises.

Navid Farzad: Managing Partner. Oversees investment strategy and operations, bringing a wealth of experience in healthcare investment and management.

Caroline Young: Vice President of Partnership Development. Joined FCV in 2021, focusing on creating engagement opportunities and supporting value creation for portfolio companies.

Leadership Changes

In July 2021, Caroline Young joined FCV as Vice President of Partnership Development. Prior to this role, she partnered with Senator Frist to establish NashvilleHealth and led the Nashville Health Care Council.

Competitor Profile

Market Insights and Dynamics

The healthcare venture capital market is characterized by significant investment in technology and service businesses aimed at improving quality of care, system integration, patient outcomes, and population health. The market has seen substantial growth, with venture capital investments in the healthcare sector reaching approximately $50 billion in 2019.

Competitor Analysis

Key competitors in the healthcare venture capital space include:

Ascension Ventures: Invests in healthcare companies that improve patient outcomes and reduce costs.

Bain Capital Ventures: Focuses on early-stage healthcare technology companies.

Echo Health Ventures: Partners with innovative healthcare companies to drive systemic change.

Heritage Group: Invests in healthcare services and technology companies.

Maverick Ventures: Focuses on healthcare and life sciences investments.

These firms, along with FCV, are members of the HITRUST Venture Capital Advisory Council, emphasizing the importance of data protection and compliance in healthcare investments.

Strategic Collaborations and Partnerships

FCV has engaged in significant collaborations to strengthen its market position and innovation capacity. In December 2019, FCV partnered with HITRUST to form the Venture Capital Advisory Council and Venture Program, focusing on integrating security and privacy into the DNA of tech startups. This collaboration aims to address information risk management and compliance challenges faced by early- to late-stage companies.

Operational Insights

FCV's strategic considerations include:

Recruiting Top Talent: Ensuring portfolio companies have strong executive leadership.

Connecting Partnerships: Leveraging FCV's extensive network to accelerate growth.

Executing Plans: Focusing on adding value through strategic support in key areas.

These considerations position FCV distinctively in the competitive landscape, emphasizing its commitment to transforming healthcare and improving lives.